Biopharma’s top 5 IPOs of 2023 (so far)

Biopharma’s top 5 IPOs of 2023 (so far)

Source: 
Pharma Voice
snippet: 

In another year defined by a turbulent market, Kenvue, Johnson & Johnson’s Consumer Health business spin-off, gave the healthcare industry its largest IPO since 2018, netting $4.24 billion.

“This is the largest healthcare IPO since Siemens spun out device company Siemens Healthineers in a $5.17 billion IPO in 2018,” said Patricia Giglio, director of deals intelligence at Citeline.